Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$420M |
| 2 |
Zoom
ZM
|
+$370M |
| 3 |
Uber
UBER
|
+$267M |
| 4 |
Intel
INTC
|
+$247M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$266M |
| 3 |
Amgen
AMGN
|
+$212M |
| 4 |
PPLI
People Inc
PPLI
|
+$207M |
| 5 |
Eli Lilly
LLY
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.49% |
| 2 | Healthcare | 14.08% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Axogen
AXGN
$2.5B
| $6.08M | ﹤0.01% |
522,892
-9,772
| -2% | -$113K |
|
2277
Syndax Pharmaceuticals
SNDX
$1.82B
| $6.08M | ﹤0.01% |
412,013
-2,677
| -0.6% | -$40.8K |
|
2278
Anterix
ATEX
$1.94B
| $6.07M | ﹤0.01% |
185,684
-13,427
| -7% | -$568K |
|
2279
Universal Insurance Holdings
UVE
$1.23B
| $6.06M | ﹤0.01% |
437,602
+6,148
| +1% | +$109K |
|
2280
Ascendis Pharma A/S
ASND
$16.8B
| $6.05M | ﹤0.01% |
39,196
+923
| +2% | +$133K |
|
2281
Community Health Systems
CYH
$423M
| $6.01M | ﹤0.01% |
1,424,900
-68,086
| -5% | -$300K |
|
2282
Global Industrial
GIC
$1.49B
| $6M | ﹤0.01% |
250,767
+5,804
| +2% | +$125K |
|
|
ISEE
2283
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6M | ﹤0.01% |
1,064,153
+499,350
| +88% | +$2.38M |
|
|
BCOV
2284
DELISTED
Brightcove, Inc.
BCOV
| $5.99M | ﹤0.01% |
584,848
+15,711
| +3% | +$157K |
|
|
LGTY
2285
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $5.98M | ﹤0.01% |
426,065
-9,129
| -2% | -$143K |
|
|
HTBK
2286
DELISTED
Heritage Commerce
HTBK
| $5.98M | ﹤0.01% |
898,484
+2,917
| +0.3% | +$20.1K |
|
2287
Ecovyst
ECVT
$1.14B
| $5.96M | ﹤0.01% |
581,105
+23,261
| +4% | +$284K |
|
|
WTRE
2288
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $5.95M | ﹤0.01% |
259,588
+103,052
| +66% | +$1.88M |
|
2289
Levi Strauss
LEVI
$9.39B
| $5.94M | ﹤0.01% |
443,441
+108,978
| +33% | +$1.38M |
|
2290
Zentalis Pharmaceuticals
ZNTL
$302M
| $5.93M | ﹤0.01% |
181,447
+19,112
| +12% | +$669K |
|
2291
Ardelyx
ARDX
$997M
| $5.93M | ﹤0.01% |
1,129,379
+23,841
| +2% | +$143K |
|
2292
Sterling Infrastructure
STRL
$16.7B
| $5.92M | ﹤0.01% |
417,818
+5,153
| +1% | +$64.7K |
|
2293
Arlo Technologies
ARLO
$1.65B
| $5.92M | ﹤0.01% |
1,124,594
+35,695
| +3% | +$172K |
|
2294
Cue Biopharma
CUE
$114M
| $5.89M | ﹤0.01% |
13,054
+479
| +4% | +$276K |
|
|
CFB
2295
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $5.89M | ﹤0.01% |
678,102
+298,073
| +78% | +$2.81M |
|
2296
BrightView Holdings
BV
$1.07B
| $5.88M | ﹤0.01% |
516,291
+70,500
| +16% | +$846K |
|
|
BRSP
2297
BrightSpire Capital
BRSP
$648M
| $5.87M | ﹤0.01% |
1,196,121
+2,306
| +0.2% | +$13.9K |
|
|
CDMO
2298
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.87M | ﹤0.01% |
769,785
+10,657
| +1% | +$80.7K |
|
2299
Community Trust Bancorp
CTBI
$1.41B
| $5.85M | ﹤0.01% |
206,924
-56,565
| -21% | -$1.78M |
|
2300
ALX Oncology
ALXO
$290M
| $5.83M | ﹤0.01% |
+154,629
| New | +$6.08M |
|
Similar funds
Geode Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Geode Capital Management held 4,244 positions worth $510B, up 9.2% from $467B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2020 filing shows 144 new, 2,112 increased, 1,496 reduced and 90 closed positions. Its largest new stake was Snowflake: 195,170 shares worth $48.9M. The largest sale was Apple, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2020 buy was Snowflake: 195,170 shares worth $48.9M.
- Geode Capital Management added most to Amazon in Q3 2020, an estimated $420M increase.
- Geode Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $421M.
- Geode Capital Management fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $84.5M.
- Geode Capital Management's ten largest holdings make up 23% of its $510B portfolio in Q3 2020.
- Geode Capital Management opened 144 new positions and closed 90 in Q3 2020.
- Geode Capital Management's portfolio value rose 9.2% quarter-over-quarter to $510B.
Based on Geode Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.